Xencor Catapults, Breaking Out On 'Unprecedented,' 'Profound' Cancer Data

Xencor stock catapulted Monday to a nearly four-year high, breaking out on positive results for its experimental kidney cancer treatment. The post Xencor Catapults, Breaking Out On 'Unprecedented,' 'Profound' Cancer Data appeared first on Investor's Business Daily.